Suppr超能文献

用铟-111 托品酸盐对人粒细胞和混合白细胞进行放射性标记的最佳条件。

Optimum conditions for radiolabelling human granulocytes and mixed leucocytes with 111In-tropolonate.

作者信息

Danpure H J, Osman S

机构信息

MRC Cyclotron Unit, Hammersmith Hospital, London, UK.

出版信息

Eur J Nucl Med. 1988;13(10):537-42. doi: 10.1007/BF00256631.

Abstract

To determine the optimum conditions for the in vitro radiolabelling of human granulocytes with 111In-tropolonate for clinical studies, the factors which affected the amount of 111In bound to the cells, the labelling efficiency (LE), were measured. These included the tropolone concentration, labelling medium and cell concentration. The tropolone concentration was dependent on the amount of plasma in the labelling medium; with 90% ACD plasma it was 4 x 10(-4) M and with Hepes saline buffer it was 4 x 10(-5) M. Using these tropolone concentrations and a low granulocyte concentration of 1 x 10(7) ml-1, the LE in 90% ACD plasma was 29% and in buffer was 74%. However, increasing the cell concentration to 1 x 10(8) ml-1 gave a LE of 90% in buffer and plasma. The optimum conditions for clinical studies involved incubating granulocytes, or mixed leucocytes as a source of granulocytes, at a cell concentration of at least 5 x 10(7) cell/ml in 1 ml ACD plasma, pH 7-7.6 with 0.1 ml tropolone at 4.4 x 10(-3) M mixed with no more than 100 microliter 111InCl3 for 15 min at room temperature. Under these conditions more than 96% of the 111In was taken up by the granulocytes and only 3% of the 111In was released from the labelled cells during a 30 min incubation in plasma. 111In-tropolonate is therefore an efficient agent for stably radiolabelling human granulocytes in plasma for clinical studies.

摘要

为确定用于临床研究的用铟 - 托酚酮对人粒细胞进行体外放射性标记的最佳条件,对影响与细胞结合的铟量即标记效率(LE)的因素进行了测定。这些因素包括托酚酮浓度、标记介质和细胞浓度。托酚酮浓度取决于标记介质中的血浆量;对于90%的ACD血浆,其浓度为4×10⁻⁴ M,对于Hepes盐水缓冲液,其浓度为4×10⁻⁵ M。使用这些托酚酮浓度以及1×10⁷ ml⁻¹的低粒细胞浓度时,在90%的ACD血浆中的标记效率为29%,在缓冲液中为74%。然而,将细胞浓度增加到1×10⁸ ml⁻¹时,在缓冲液和血浆中的标记效率达到90%。临床研究的最佳条件包括将粒细胞或作为粒细胞来源的混合白细胞,以至少5×10⁷个细胞/ml的细胞浓度,在1 ml pH 7 - 7.6的ACD血浆中,与0.1 ml 4.4×10⁻³ M的托酚酮混合,再加入不超过100微升的¹¹¹InCl₃,在室温下孵育15分钟。在这些条件下,超过96%的¹¹¹In被粒细胞摄取,并且在血浆中孵育30分钟期间,只有3%的¹¹¹In从标记细胞中释放出来。因此,铟 - 托酚酮是用于临床研究的在血浆中稳定放射性标记人粒细胞的有效试剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验